Human medicines European public assessment report (EPAR): Dimethyl fumarate Accord, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 2, Status: Authorised
First vaccine against epizootic haemorrhagic disease recommended for approval
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 March 2025
Summary of opinion: Rheumocam, 13/03/2025 Positive
EMEA-002566-PIP01-19-M01
Frequently asked questions
EMEA-002559-PIP09-23
Frequently asked questions (FAQs): How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10
Opinion/decision on a Paediatric investigation plan (PIP): Litfulo, Ritlecitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0026/2024
Opinion/decision on a Paediatric investigation plan (PIP): Sotyktu, Deucravacitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0008/2024